Many NET patients have livers that could be considered compromised. Does COVID-19 pose specific liver concerns or harm--either from the virus or treatments?


At this point, we do not believe that COVID-19 poses a risk to the liver. At present, there are no specific treatments approved by the Food and Drug Administration (FDA) to treat people with COVID-19, the disease caused by the virus SARS-CoV-2. Some hospitals are trying antiviral treatments approved for other indications, such as remdesivir, which is already in clinical trials for COVID-19. Some other medications are used to treat the more serious problems associated with the infection (like lung inflammation). One such drug being used to treat severe lung inflammation associated with COVID-19 is called tocilizumab, and a known side effect can be abnormal liver function tests.

Posted 4 months agoby globeseek